Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate Stapokibatrt in children with atopic dermatitis is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stapokibatrt

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: NOT_YET_RECRUITING